NCT02610894 is a NA clinical trial of mHealth application (PoCAH) in Orthopaedic Surgery, sponsored by Jan Odom Forren.

Who is sponsoring NCT02610894?

NCT02610894 is sponsored by Jan Odom Forren.

What drugs are being tested in NCT02610894?

Interventions in NCT02610894: mHealth application (PoCAH), As usual standard discharge and care instructions.

What condition does NCT02610894 study?

NCT02610894 studies Orthopaedic Surgery.

Is NCT02610894 still recruiting?

NCT02610894 is currently completed. Last updated 22 October 2018.

Last reviewed 2018-10-22 · How we verify

NCT02610894

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An mHealth Self-Management Program to Decrease Postoperative Symptom Distress

Completed NA Last updated 22 October 2018

What this trial tests

NA trial testing mHealth application (PoCAH) in Orthopaedic Surgery in 40 participants. Completed in 25 July 2016.

Timeline

7 October 2015

Primary endpoint
25 July 2016

25 July 2016

Quick facts

Lead sponsor	Jan Odom Forren
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	40
Start date	7 October 2015
Primary completion	25 July 2016
Estimated completion	25 July 2016
Sites	1 location across United States

Drugs / interventions tested

mHealth application (PoCAH)
As usual standard discharge and care instructions

Conditions studied

Orthopaedic Surgery — all drugs for Orthopaedic Surgery →

Sponsor

Jan Odom Forren

Who can join

18 and older, any sex, with Orthopaedic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purposes of this study are to determine if use of the Postoperative Care at Home (PoCAH) tailored self-management program delivered via mobile technology (a mobile app) after discharge to home will result in: 1) fewer and/or less intense patient symptoms (pain, nausea and vomiting, fatigue, sore throat, constipation, sleep dysfunction); 2) enhanced patient satisfaction, perceived self-efficacy, and quality of life; 3) lower healthcare resource use (patient to healthcare provider calls; unscheduled patient appointments with healthcare providers; and hospital readmission and emergency department use). A secondary objective is to assess how easy the mobile app was to use after orthopaedic ambulatory surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Beyond the Randomized Controlled Trial: A Review of Alternatives in mHealth Clinical Trial Methods.
Pham Q, Wiljer D, Cafazzo JA. · · 2016 · cited 113× · PMID 27613084 · DOI 10.2196/mhealth.5720

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02610894 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jan Odom Forren
Last refreshed: 22 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02610894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing